Gino In
|
Title(s) | Assistant Professor of Clinical Medicine |
---|
Address | NOR 3440 NTT Health Sciences Campus Los Angeles CA 90089-9324
|
---|
Phone | +1 323 226 7622 |
---|
vCard | Download vCard |
---|
|
|
Biography University of Southern California, Los Angeles, CA | Fellowship | 2016 | Hematology/Oncology | SUNY Downstate Medical Center, Brooklyn, NY | Residency | 2011 | Internal Medicine | SUNY Downstate Medical Center, Brooklyn, NY | Internship | 2010 | | Ross University, North Brunswick Township, NJ | MD | 2010 | Medicine | Emory University, Atlanta, GA | MPH | 2006 | Environmental/Occupational Health | Emory University, Atlanta, GA | BS | 2002 | |
University of Southern California | | | Chief Medical Oncology Fellow |
Overview Gino K. In, MD, MPH, is a medical oncologist who specializes in solid tumor and cutaneous oncology. He completed his fellowship training in hematology and oncology at the University of Southern California, Keck School of Medicine, where he was the chief medical oncology fellow. He subsequently joined the USC Norris Comprehensive Cancer Center, and now serves as Assistant Professor of Clinical Medicine in the Division of Oncology, and Assistant Professor of Dermatology. Dr. In’s research focus includes the multi-disciplinary management of melanoma and other skin cancers, including cutaneous squamous cell carcinoma, basal cell carcinoma and Merkel cell carcinoma. He has a specific interest in non-UV related melanoma subtypes and intratumoral therapies. Dr. In is the lead primary investigator for cutaneous oncology clinical trials at USC, including studies through the National Cancer Institute, California Cancer Consortium, and Southwest Oncology Group.
Medical Oncology, Skin Cancer, Melanoma, Acral Lentiginous Melanoma, Uveal Melanoma, Mucosal Melanoma, Squamous Cell Carcinoma, Basal Cell Carcinoma, Merkel Cell Carcinoma, Dermatofibrosarcoma Protuberans, Porocarcinoma
ORNG Applications Bibliographic
Altmetrics Details
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media.
(Note that publications are often cited in additional ways that are not shown here.)
Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication.
Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.)
Click a Field or Translation tag to filter the publications.
-
The Importance of Understanding the Stages of COVID-19 in Treatment and Trials. AIDS Rev. 2021 02 08.
PMID: 33556957.
View in: PubMed Mentions: Fields:
-
18F-FDG PET/CT Monitoring of Response to Programmed Death Protein 1 Blockade in Metastatic Basal Cell Carcinoma. Clin Nucl Med. 2021 Jan 28.
Jadvar H, In GK. PMID: 33512957.
View in: PubMed Mentions: Fields:
-
COVID-19 Outcomes of Patients With Differentiated Thyroid Cancer: A Multicenter Los Angeles Cohort Study. Endocr Pract. 2021 Feb; 27(2):90-94.
PMID: 33551317.
View in: PubMed Mentions: Fields: Translation: Humans
-
Impact of COVID-19 infection among cancer patients treated at the Los Angeles County Medical Center. Cancer Treat Res Commun. 2020 Dec 10; 26:100273.
Antrim L, Capone S, Dong S, Chung D, Lin S, Wald-Dickler N, In GK. PMID: 33338856.
View in: PubMed Mentions: Fields: Translation: Humans
-
PD-1 inhibition therapy for advanced cutaneous squamous cell carcinoma: a retrospective analysis from the University of Southern California. J Cancer Res Clin Oncol. 2020 Nov 18.
In GK, Vaidya P, Filkins A, Hermel DJ, King KG, Ragab O, Tseng WW, Swanson M, Kokot N, Lang JE, Menendez L, DeClerck B, Kim G, Hu JC, Terando A, Jadvar H, Ricker C, Miller KA, Peng DH, Wysong A. PMID: 33210210.
View in: PubMed Mentions: Fields:
-
Prevalence of class I-III BRAF mutations among 114,662 cancer patients in a large genomic database. Exp Biol Med (Maywood). 2021 Jan; 246(1):31-39.
PMID: 33019809.
View in: PubMed Mentions: Fields:
-
Molecular profiling of melanoma brain metastases compared to primary cutaneous melanoma and to extracranial metastases. Oncotarget. 2020 Aug 18; 11(33):3118-3128.
In GK, Poorman K, Saul M, O'Day S, Farma JM, Olszanski AJ, Gordon MS, Thomas JS, Eisenberg B, Flaherty L, Weise A, Daveluy S, Gibney G, Atkins MB, Vanderwalde A. PMID: 32913556.
View in: PubMed Mentions: Fields:
-
Rapidly Progressive Porocarcinoma of the Ear and Multidisciplinary Approach to Management. Dermatol Surg. 2020 Mar 04.
Rabi S, Syder N, Ragab O, In G, Hu JC. PMID: 32141925.
View in: PubMed Mentions: Fields:
-
Comparison of the biomarkers for targeted therapies in primary extra-mammary and mammary Paget's disease. Cancer Med. 2020 02; 9(4):1441-1450.
Gatalica Z, Vranic S, Krušlin B, Poorman K, Stafford P, Kacerovska D, Senarathne W, Florento E, Contreras E, Leary A, Choi A, In GK. PMID: 31899853.
View in: PubMed Mentions: 4 Fields:
-
Clinical Update on Checkpoint Inhibitor Therapy for Conjunctival and Eyelid Melanoma. Int Ophthalmol Clin. 2020; 60(2):77-89.
Lu JE, Chang JR, Berry JL, In GK, Zhang-Nunes S. PMID: 32205655.
View in: PubMed Mentions: Fields:
-
Prevalence and correlates of adherence to skin examination among adolescent and young adult survivors of melanoma from the Project Forward Study. Pediatr Blood Cancer. 2020 03; 67(3):e28090.
Miller KA, Wojcik KY, Cockburn MG, In GK, Hamilton AS, Milam JE. PMID: 31774240.
View in: PubMed Mentions: Fields: Translation: Humans
-
Concurrent radiation therapy with programmed cell death protein 1 inhibition leads to a complete response in advanced cutaneous squamous cell carcinoma. JAAD Case Rep. 2019 Sep; 5(9):763-766.
Vaidya P, Mehta A, Ragab O, Lin S, In GK. PMID: 31516991.
View in: PubMed Mentions:
-
Skin cancer and dermatoses in a majority-Hispanic population of solid organ transplant recipients. J Am Acad Dermatol. 2020 Aug; 83(2):607-610.
Adler BL, Smogorzewski J, Sierro T, Shauly O, Osipchuk D, Miller M, Mert M, Fong MW, Ganesh S, Han H, In GK, Maw TT, Smogorzewski M, Hu J, Ngo B, Lee D, Ahronowitz I. PMID: 31400454.
View in: PubMed Mentions: Fields:
-
Two synchronous malignancies: nodular melanoma and renal cell carcinoma in a patient with an underlying germline BRCA2 mutation. BMJ Case Rep. 2019 Jun 20; 12(6).
Snow A, Ricker C, In GK. PMID: 31227566.
View in: PubMed Mentions: Fields: Translation: Humans
-
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance. Nat Commun. 2019 04 12; 10(1):1693.
Li S, Song Y, Quach C, Guo H, Jang GB, Maazi H, Zhao S, Sands NA, Liu Q, In GK, Peng D, Yuan W, Machida K, Yu M, Akbari O, Hagiya A, Yang Y, Punj V, Tang L, Liang C. PMID: 30979895.
View in: PubMed Mentions: 21 Fields: Translation: HumansAnimalsCells
-
Cetuximab as a Component of Multimodality Treatment of High-Risk Cutaneous Squamous Cell Carcinoma: A Retrospective Analysis From a Single Tertiary Academic Medical Center. Dermatol Surg. 2019 02; 45(2):254-267.
Trodello C, Higgins S, Ahadiat O, Ragab O, In G, Hawkins M, Wysong A. PMID: 30672860.
View in: PubMed Mentions: 3 Fields: Translation: Humans
-
Talimogene laherparepvec in combination with pembrolizumab leads to a complete response in a patient with refractory Merkel cell carcinoma. JAAD Case Rep. 2018 Nov; 4(10):1004-1006.
Lara KM, In GK, Matcuk GR, Mehta A, Hu JS. PMID: 30450405.
View in: PubMed Mentions:
-
Eccrine Porocarcinoma: New Insights and a Systematic Review of the Literature. Dermatol Surg. 2018 10; 44(10):1247-1261.
Nazemi A, Higgins S, Swift R, In G, Miller K, Wysong A. PMID: 29894433.
View in: PubMed Mentions: 2 Fields: Translation: Humans
-
Development of metastatic brain disease involves progression through lung metastases in EGFR mutated non-small cell lung cancer. Converg Sci Phys Oncol. 2017 Sep; 3(3).
In G, Mason J, Lin S, Newton PK, Kuhn P, Nieva J. PMID: 30283700.
View in: PubMed Mentions:
-
Development of metastatic brain disease involves progression through lung metastases in EGFR mutated non-small cell lung cancer. Convergent Science Physical Oncology. 2017; 3(3).
In GK, Mason J, Lin S, Newton P, Kuhn P, Nieva J.
-
Skin Cancer Prevention Among Hispanics: a Review of the Literature. Epidemiology. 2017.
Miller KA, In GK, Jiang SY, Ahadiat O, Higgins S, Wysong A, Cockburn MG.
-
Treatment of advanced, metastatic soft tissue sarcoma: latest evidence and clinical considerations. Ther Adv Med Oncol. 2017 Aug; 9(8):533-550.
In GK, Hu JS, Tseng WW. PMID: 28794805.
View in: PubMed Mentions:
-
Emerging Chemotherapy Agents in Lung Cancer: Nanoparticle Therapeutics for Non-Small Cell Lung Cancer. Transl Cancer Res. 2015; 4(4):340-355.
In GK, Nieva J. View Publication.
-
Chemotherapy for Good-Risk Nonseminomatous Germ Cell Tumors: Current Concepts and Controversies. Urol Clin North Am. 2015 Aug; 42(3):347-57.
PMID: 26216822.
View in: PubMed Mentions: Fields: Translation: Humans
This graph shows the total number of publications by year. To see the data as text, click here.
This graph shows the total number of publications by year. To return to the graph, click here.
Year | Publications |
---|
2015 | 2 | 2017 | 4 | 2018 | 2 | 2019 | 6 | 2020 | 7 | 2021 | 3 |
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text, click here.
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text, click here.
newest
oldest
line numbers
double spacing
all authors
publication IDs
|
Derived automatically from this person's publications.
_
People in Profiles who have published with this person.
_
People who share similar concepts with this person.
_
Search Department
_
|